Virology News

Jeffrey Taubenberger (NIAID) and John Oxford (QMUL) are invited to speak at The Norwegian Academy of Science and Letters as guests of Mamelund’s CAS project.Supported by the Centre for Advanced Study (CAS) at The Norwegian Academy of Science and Letters.‘The influenza...

The amount of highly pathogenic avian influenza outbreaks in Europe in 2021 quadrupled that of 2020.

A repository of stories of anti-vaxxers who died or came close to dying of COVID.

A new study clarifies how L-dopa, the front-line drug for Parkinson's disease, also contributes to the rapid decline in quality of life over time.

LYNCHBURG, VA—Astounded by the damning information, local anti-vaxxer Pete Dixon was reportedly horrified Thursday after discovering that every single American who got a smallpox vaccine in the 19th century was now deceased.

Influenza has returned to Europe at a faster-than-expected rate this winter after almost disappearing last year, raising concerns about a prolonged "twindemic" with COVID-19 amid some doubts about the effectiveness of flu vaccines.

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab...

Flu outbreaks continue to be a major crisis in the poultry industry.The year didn't start so well for poultry farmers in Burkina Faso, not only did it affect...

This terrible Covid and flu season is a preview of the post-pandemic normal.

Better to wash hands than wait for a vaccine with this potential pandemic...

Porcine circovirus type 3 (PCV3), a novel circovirus, imposes great burdens on the global pig industry. The penside tests for detecting PCV3 are critical for assessing the epidemiological status and working out disease prevention and control programs due to the unavailability of a commercial...

A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.

Flow cytometric data were analyzed using FlowJo version 10.7.1 (BD Biosciences). Multiplex cytokine bead data were analyzed using the LEGENDplex Data Analysis Software Suite (BioLegend). Statistical analyses were performed using GraphPad Prism version 9.1.1. Δ in figures represents values for which the corresponding background signal for each donor had been subtracted. “Background signal” is defined as the frequency of cells expressing the parameter being analyzed, or concentration of an analyte, in negative control wells. For each donor, the response is reported as the Δ after background subtraction for that donor. A T cell response was defined as positive if the value was two times background for that sample, and above a minimal level of 0.003%, which is calculated as the median of all DMSO controls. To calculate the rate of decay of the CD4 T cell responses based on ICC responses, we focused only on the stronger responses, and we only included donors whose response was 2 SDs above the median background. For proliferation data, in calculating the distribution of CD4 or CD8 subsets, only positive results were included, defined as above. For the multiplex data, the limit of detection was established using a standard curve for each analyte. Pairwise comparisons were made by a two-tailed Wilcoxon test or a nonparametric Dunn’s multiple comparisons test. Correlation analyses were performed by computing the Spearman correlation coefficient. For longitudinal data, the percentage change over time and t1/2 were calculated after linear regression was performed for each donor. We report the average percentage change per week and the average t1/2. Cluster analysis for multiplex data were performed by first calculating fold change in response to an Ag and then performing hierarchical agglomerative clustering on log-transformed data. Values across donors were standardized by minimum/maximum normalization such that, for each analyte, the minimum is subtracted, then divided by its maximum. These data were visualized using the Seaborn data visualization library for Python (https://joss.theoj.org/papers/10.21105/joss.03021).

​Moderna is poised to commercialize its COVID-19 and influenza combination vaccine by the fall of 2023, with some potential for the same drug to also be viable against the RSV.

It would have been hard to know in March 2020 that Covid-19 testing limitations in New York City would help lead doctors at Montefiore Medical Center in the Bro...

The 1918 Influenza epidemic in South Africa exacerbated existing large racial inequalities in access to institutionalized medical treatment...

Novak Djokovic risks being frozen out of tennis as he chases a record 21st Grand Slam title, with rules on travellers who are unvaccinated against COVID-19 tightening in the third year of the pandemic and some tournaments reconsidering exemptions.

Two vaccines will soon be tested in France in response to the worst avian influenza outbreak Europe has ever faced, French Agriculture Minister Julien Denormandie has announced. The aim is for them to be approved for all 27 EU member states.

Vets had the unfortunate task of putting down 26 of the swans on the Thames after six were pulled from the river earlier in January...

A repurposed ADHD medication that boosts norepinephrine levels could stall neurodegeneration in people with early signs of Alzheimer’s disease.

"Doomscrolling" isn't just a new name for an existing behavior, researchers say. It's a unique behavior all its own, according to a new study.